Nicholas van As (@nickva1) header
Nicholas van As (@nickva1) profile picture

Nicholas van As

@nickva1

Consultant Oncologist @royalmarsdenNHS Oncologist, Professor @ICR_London dad to 4, pretend cyclist (views my own)

 London, England
Joined March 2009
  • Tweets1.3K
  • Following282
  • Followers2.2K
169Media
Photo by Nicholas van As (@nickva1)Photo by Nicholas van As (@nickva1)Photo by Nicholas van As (@nickva1)Photo by Nicholas van As (@nickva1)Photo by Nicholas van As (@nickva1)Photo by Nicholas van As (@nickva1)Photo by Nicholas van As (@nickva1)Photo by Nicholas van As (@nickva1)Photo by Nicholas van As (@nickva1)Photo by Nicholas van As (@nickva1)
Nicholas van As retweeted
Alan Tan (@alantanmd) profile picture
Alan Tan
@alantanmdOct 24
One year of APA+ADT comes with toxicity, and outcomes after control-arm salvage aren't shown. His view: follow-up too short; would not yet support perioperative APA+ADT with RP in high-risk disease, needing mature survival and post-salvage data first.
Image from Alan Tan (@alantanmd)
Image from Alan Tan (@alantanmd)
Image from Alan Tan (@alantanmd)
Image from Alan Tan (@alantanmd)
3
7
444
Nicholas van As retweeted
Alan Tan (@alantanmd) profile picture
Alan Tan
@alantanmdOct 24
#ESMO26 PROTEUS discussion by Nicholas van As • No baseline PSMA PET; enrolled conventionally staged M0 • MFS events: true progression or delayed detection? Most were PSMA PET-detected (8.8% vs 16.3%) • TTST HR 0.29, but ~20-mo lead-time bias #ProstateCancer
Image from Alan Tan (@alantanmd)
Image from Alan Tan (@alantanmd)
Image from Alan Tan (@alantanmd)
Image from Alan Tan (@alantanmd)
3
25
2
55
4,174
Nicholas van As retweeted
Drew Moghanaki (@DrewMoghanaki) profile picture
Drew Moghanaki
@DrewMoghanakiSep 30
Freddie has been officially immortalized. He will always be remembered for his vision, commitment, and passion in working with Jenny Donovan and the rest of the ProtecT team to forever change the way we think about men affected by prostate cancer. I remain deeply saddened to learn he has pancreatic cancer, yet so happy he’s still doing well 5 years after the diagnosis. @QuinteTBristol @NehaVapiwala @TylerSbrt
Drew Moghanaki (@DrewMoghanaki) profile pictureDrew Moghanaki
@DrewMoghanakiSep 29
Replying to @DrewMoghanaki
VIDEO for Dr. Hamdy’s inspiring acceptance: youtu.be/M_Fm-mgXIKs?is=Xeyn…
Image from Drew Moghanaki (@DrewMoghanaki)
3
10
1,620
An honour to present the efficacy results of #PACE_A in the plenary and sexual function in the LBA at #ASTRO26 Take home message-give patients the data, let them make an informed choice
Image from Nicholas van As (@nickva1)
Image from Nicholas van As (@nickva1)
Image from Nicholas van As (@nickva1)
Image from Nicholas van As (@nickva1)
4
40
1
102
4,567
Image from Nicholas van As (@nickva1)
Image from Nicholas van As (@nickva1)
Image from Nicholas van As (@nickva1)
2
10
1
14
1,179
Image from Nicholas van As (@nickva1)
5
13
536
Nicholas van As retweeted
Nat Lester-Coll, MD (@DrLesterColl) profile picture
Nat Lester-Coll, MD@DrLesterCollSep 28
#ASTRO26 @nickva1 presents 5 yr data of PACE-A: SBRT v RP no differences in clinical outcomes use of =1 urinary pad 8.3% SBRT V 48% RP Low GI/GU events <%4 each arms
Image from Nat Lester-Coll, MD (@DrLesterColl)
Image from Nat Lester-Coll, MD (@DrLesterColl)
1
11
19
1,711
Nicholas van As retweeted
Alison Tree 💙 (@alison_tree) profile picture
Alison Tree 💙@alison_treeSep 28
Replying to @nickva1
@nickva1 @royalmarsdenNHS presenting 5 year outcomes of PACE-A @EmmaHall71 Surprised to see numerically less bowel bother in the SBRT arm, noting small numbers. Await sexual outcome data tomorrow @ASTRO_org #ASTRO26
Image from Alison Tree 💙 (@alison_tree)
Image from Alison Tree 💙 (@alison_tree)
Image from Alison Tree 💙 (@alison_tree)
2
18
1
48
2,621
Nicholas van As retweeted
Clive Peedell (@cpeedell) profile picture
Clive Peedell@cpeedellSep 28
Replying to @DrLesterColl @nickva1
I would call that a massive difference in clinical outcomes! (I know what you mean though!)
1
2
505
Nicholas van As retweeted
Zach Klaassen (@zklaassen_md) profile picture
Zach Klaassen
@zklaassen_mdSep 28
#ASTRO26 Plenary -- PACE-A: 5-yr Outcomes of RP vs SBRT for GG1-2 PCa @nickva1 @urotoday 📍n=123 (60 RP, 63 SBRT), mFU 8 yrs, 10 🇬🇧 centers 📍13 BCF events: HR 0.48, 95% CI 0:16-1.46 📍7 deaths (no PCa): HR 0.55, 95% CI 0.12, 2.46 📍EPIC-26 >=1 urinary pad: 14/29 (48%) RP vs 3/36 (8%) SBRT 📍EPIC-26 bowel bother: 1/28 (4%) RP vs 0 SBRT
Image from Zach Klaassen (@zklaassen_md)
Image from Zach Klaassen (@zklaassen_md)
Image from Zach Klaassen (@zklaassen_md)
Image from Zach Klaassen (@zklaassen_md)
14
19
2
42
17,203
Nicholas van As retweeted
Urology Times (@UrologyTimes) profile picture
Urology Times
@UrologyTimesSep 28
#ASTRO26: PACE-A showed 8-year biochemical/clinical failure-free rates of 91% with SBRT vs 84% with prostatectomy, although the difference was not statistically significant. SBRT also showed less urinary incontinence at 5 years. @nickva1 urologytimes.com/view/sbrt-p…
SBRT, prostatectomy show comparable long-term disease control in PACE-A trial | Urology Times

SBRT, prostatectomy show comparable long-term disease control in PACE-A trial | Urology Times

In the phase 3 PACE-A trial, SBRT and prostatectomy showed similar 8-year disease control in localized prostate cancer, with lower rates of urinary incontinence after SBRT.

urologytimes.com
1
2
5
998
#ASTRO26 @ASTRO_org Plennary session II #SBRT #ProstateCancer #PaceB @nickva1 Time of change
Image from José Máximo Barros, MD 🇦🇷 (@barrosonco)
Image from José Máximo Barros, MD 🇦🇷 (@barrosonco)
Image from José Máximo Barros, MD 🇦🇷 (@barrosonco)
Image from José Máximo Barros, MD 🇦🇷 (@barrosonco)
2
3
376
Nicholas van As retweeted
Kate Sears (@OpenMedKate) profile picture
Kate Sears
@OpenMedKateSep 18
Hi friends, it's #ProstateCancer Friday! Here are Top Posts of the Week 🧵 1/ @nickva1 on the recent @EUplatinum focal therapy paper: nitter.cf/nickva1/status/2098359…
Nicholas van As (@nickva1) profile pictureNicholas van As@nickva1Sep 11
Please see our letter @alison_tree @piet_ost in response to the recent Focal therapy paper in @EUplatinum authors.elsevier.com/a/1nlq2… @LondonProstate1 @mrsprostate @taimurShah @ASTRO_org @ESTRO_RT
1
4
14
1,264
Really important trial, and great to see 202 pts recruited. Well done!!
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
1
1
10
1,978
Please see our letter @alison_tree @piet_ost in response to the recent Focal therapy paper in @EUplatinum authors.elsevier.com/a/1nlq2… @LondonProstate1 @mrsprostate @taimurShah @ASTRO_org @ESTRO_RT
4
29
6
67
18,108
Nicholas van As retweeted
Sian Cooper (@DrSACooper) profile picture
Sian Cooper@DrSACooperJul 23
💬 What do patients say about their long term quality of life after prostate radiotherapy? Find out from the practice-changing PACE-B trial here 👉 doi.org/10.1016/j.eururo.202…
6
13
1
23
4,681
10 billion will buy some lovely horses 😊
Dr Simon (@DrSimonsTravels) profile pictureDr Simon@DrSimonsTravelsJun 12
If I ever become a trillionaire, I’ll give 99% to good causes and buy a load of racehorses with the rest Bookmark this tweet to remind me please
624
Great data!
Vedang Murthy (@VedangMurthy) profile pictureVedang Murthy@VedangMurthyMay 17
Very proud of my whole team esp @indranilsays for brilliantly presenting the 1y AE data of the largest RCT in HR and N+ CaP. SBRT is safe! Gr 3 AE very low. More to follow....
Image from Vedang Murthy (@VedangMurthy)
Image from Vedang Murthy (@VedangMurthy)
Image from Vedang Murthy (@VedangMurthy)
Image from Vedang Murthy (@VedangMurthy)
1
6
1,116
Great study @alison_tree and lovely presentation @DrSACooper
Alison Tree 💙 (@alison_tree) profile pictureAlison Tree 💙@alison_treeMay 17
Great presentation by @DrSACooper @ESTRO_RT showing low adverse events in both 5 and 2 fraction MRI-guided adaptive radiotherapy (HERMES trial), with minimal impact on quality of life in both arms.
Image from Alison Tree 💙 (@alison_tree)
Image from Alison Tree 💙 (@alison_tree)
1
7
532
Load more